These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18654355)

  • 1. Does REACH go too far?
    Bowman DM; van Calster G
    Nat Nanotechnol; 2007 Sep; 2(9):525-6. PubMed ID: 18654355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comment on the combined position of the state government, the union of the chemical industry and the industrial mining association, chemistry, energy for the White Paper of the European Commission "Strategy for future Chemical Policy"].
    Sauer U
    ALTEX; 2002; 19(2):106-7. PubMed ID: 12098015
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanotechnology. EPA ponders voluntary nanotechnology regulations.
    Service RF
    Science; 2005 Jul; 309(5731):36. PubMed ID: 15994499
    [No Abstract]   [Full Text] [Related]  

  • 4. Tighter nanotech regulations touted.
    Sanderson K
    Nature; 2009 Feb; 457(7230):647. PubMed ID: 19194417
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanotech under scrutiny, but tighter regulation remains distant.
    Kling J
    Nat Biotechnol; 2007 Oct; 25(10):1068. PubMed ID: 17921977
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory approaches to worker protection in nanotechnology industry in the USA and European union.
    Murashov V; Schulte P; Geraci C; Howard J
    Ind Health; 2011; 49(3):280-96. PubMed ID: 21372443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The US must help set international standards for nanotechnology.
    Murashov V; Howard J
    Nat Nanotechnol; 2008 Nov; 3(11):635-6. PubMed ID: 18989319
    [No Abstract]   [Full Text] [Related]  

  • 8. Too small to overlook.
    Maynard A; Rejeski D
    Nature; 2009 Jul; 460(7252):174. PubMed ID: 19587746
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating small things: genes, gametes and nanotechnology.
    Bennett B
    J Law Med; 2007 Aug; 15(1):153-60. PubMed ID: 17902497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new regulatory state: the social powers of the European Union.
    Walby S
    Br J Sociol; 1999 Mar; 50(1):118-40. PubMed ID: 15266677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brussels backs nanotech.
    Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
    [No Abstract]   [Full Text] [Related]  

  • 12. Fractured European market undermines biosimilar launches.
    Moran N
    Nat Biotechnol; 2008 Jan; 26(1):5-6. PubMed ID: 18183000
    [No Abstract]   [Full Text] [Related]  

  • 13. Optometry and optics in Europe.
    Naroo SA; Grit F
    Cont Lens Anterior Eye; 2009 Jun; 32(3):101-2. PubMed ID: 19410182
    [No Abstract]   [Full Text] [Related]  

  • 14. Safe- and sustainable-by-design: The case of Smart Nanomaterials. A perspective based on a European workshop.
    Mech A; Gottardo S; Amenta V; Amodio A; Belz S; Bøwadt S; Drbohlavová J; Farcal L; Jantunen P; Małyska A; Rasmussen K; Riego Sintes J; Rauscher H
    Regul Toxicol Pharmacol; 2022 Feb; 128():105093. PubMed ID: 34864125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inconvenient version of events.
    Monastra G
    Nat Biotechnol; 2008 Apr; 26(4):379; discussion 379-80. PubMed ID: 18392011
    [No Abstract]   [Full Text] [Related]  

  • 16. CEN Workshop establishes an international Laboratory Biorisk Management Standard.
    Rüdelsheim P
    N Biotechnol; 2008; 25(2-3):117-8. PubMed ID: 18824151
    [No Abstract]   [Full Text] [Related]  

  • 17. New European guidance on borderline products.
    Donawa ME;
    Med Device Technol; 2009 Sep; 20(5):22, 24-5. PubMed ID: 19852178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does standardisation have a role in nanotechnology and medicine?
    Moore R
    Med Device Technol; 2004 Mar; 15(2):28. PubMed ID: 15154337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology: A little knowledge..
    Brumfiel G
    Nature; 2003 Jul; 424(6946):246-8. PubMed ID: 12867950
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction: The challenge of developing oversight approaches to nanobiotechnology.
    Paradise J; Wolf SM; Kuzma J; Ramachandran G; Kokkoli E
    J Law Med Ethics; 2009; 37(4):543-5. PubMed ID: 20122099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.